Predicting Powder Blend Flowability from Individual Constituent Properties Using Machine Learning

利用机器学习从各组分特性预测粉末混合物的流动性

阅读:2

Abstract

PURPOSE: Predicting powder blend flowability is necessary for pharmaceutical manufacturing but challenging and resource-intensive. The purpose was to develop machine learning (ML) models to help predict flowability across multiple flow categories, identify key predictive features, and arrive at formulations with improved flow properties. METHODS: A dataset of 410 blends, composed of 9 active pharmaceutical ingredients (APIs) and 18 excipients with varying silica dry-coating parameters, was analyzed. Supervised ML models were trained to predict various flowability categories (very cohesive, cohesive, semi-cohesive, well-flowing, and free-flowing). Particle size, morphology, surface properties, and coating parameters were used as features. Classification algorithms, including Random Forest (RF) and Extreme Gradient Boosting (XGBoost), were evaluated. Unsupervised clustering identified natural groupings within flowability data. RESULTS: The best-performing models achieved up to 85% accuracy for predicting flowability regimes of individual components and 87% for blends. Individual components generally showed higher accuracy than blends, except in the uncoated scenario with 2 flow regimes, where blends outperformed with 94.67%. SHapley Additive exPlanations (SHAP) and Feature Importance analysis indicated dry coating parameters as the most influential factors, followed by particle size and morphology. ML models effectively identified category transitions between flow regimes, offering insights into blend optimization. CONCLUSION: Integrating ML with mechanistic approaches effectively predicted powder blend flowability across diverse categories and elucidated feature-property relationships. These outcomes can facilitate the rational design of blends having enhanced flow properties at reduced experimental effort through judiciously selected dry coating of a blend constituent; making this approach promising for advancing pharmaceutical process and product development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。